Adtimes_Sun Pharma_2018.pdf - AD-Times 2018-19 Company Name...

This preview shows page 1 - 4 out of 9 pages.

AD-Times2018-19Company Name: Sun Pharma
Background image
Industry – Bird’s Eye ViewThe pharmaceutical sector was valued at US$ 33 billion in 2017The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 201520 to reach US$ 55 billion.India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18 and are expected to reach US$ 20 billion by 2020Indian drugs are exported to more than 200 countries in the world, with the US as the key marketsource:--pharmaceuticals-industry-analysis-presentation
Background image
Sun Pharma IntroductionSun Pharmaceuticals was established by Mr. Dilip Shanghvi in 1983 in Vapi, Gujarat with five products to treat psychiatry ailments Today, it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopedics, ophthalmology, gastroenterology and nephrologyOver 72% of Sun Pharma sales are from markets outside India, primarily in the USSun Pharma Stock price Source:-ockpricequote/pharmaceuticals/sunpharmaceuticalindustries/SPI
Background image
Image of page 4

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture